Identifying new drugs for the treatment of retinoblastoma
Testing new targeted drugs for retinoblastoma to find new treatment options.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Testing new targeted drugs for retinoblastoma to find new treatment options.
Investigating the best follow up methods for childhood leukaemia to improve aftercare.
Investigating how antibody immunotherapy causes pain and nerve damage.
Using a new way to measure genetic variation in key sections of noncoding DNA.
Finding which MEK inhibitors work best for children with acute myeloid leukaemia.
Helping children in sub-Saharan Africa with endemic Burkitt Lymphoma get diagnosed earlier.
Stopping protein activity to stop anaplastic large cell lymphomas from growing.
Looking at molecular makeup and MRIs to characterise infant ependymoma.
Testing nanoparticles as a way of getting drugs where they are needed for acute myeloid leukaemia.